Phase 1 Safety, Pharmacokinetics, and Fluorescence Imaging Study of Tozuleristide (BLZ-100) in Adults With Newly Diagnosed or Recurrent GliomasNEUROSURGERYIF3.92019-10-0182PREAI
Real-time Visualization of Breast Carcinoma in Pathology Specimens From Patients Receiving Fluorescent Tumor-Marking Agent TozuleristideARCHIVES OF PATHOLOGY & LABORATORY MEDICINEIF3.22018-12-1424OAAI
A fitst-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and fluorescence contrast in skin cancerJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72018-05-010OAAI
BLZ-100 provides optical contrast in animal models of breast cancerCANCER RESEARCHIF16.62016-07-150PRE
Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green ConjugateJAMA OTOLARYNGOLOGY-HEAD & NECK SURGERYIF5.62016-04-0139OAAI
Preclinical Validation of the Utility of BLZ-100 in Providing Fluorescence Contrast for Imaging Spontaneous Solid TumorsCANCER RESEARCHIF16.62015-10-1476OAAI
Tumor Paint™ technology detects naturally occurring solid tumors in dogsCANCER RESEARCHIF16.62014-10-010PRE
Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumorsNEUROSURGICAL FOCUSIF32014-02-01131OAAI
Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17FJOURNAL OF IMMUNOLOGYIF3.42007-10-15362OAAI
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice (vol 5, pg 752, 2004)NATURE IMMUNOLOGYIF27.62005-01-016OAAI
Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in miceNATURE IMMUNOLOGYIF27.62004-06-06890PREAI
Cytokine-receptor pairing: Accelerating discovery of cytokine functionNATURE REVIEWS DRUG DISCOVERYIF101.82004-02-0132PREAI
A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonistPROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICAIF9.12001-07-31238OAAI